
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 460043
[patent_doc_number] => 07241754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-10
[patent_title] => '2-Desmethyl ansamycin compounds'
[patent_app_type] => utility
[patent_app_number] => 10/868724
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9817
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868724 | 2-Desmethyl ansamycin compounds | Jun 13, 2004 | Issued |
Array
(
[id] => 7127909
[patent_doc_number] => 20050059653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Novel crystalline forms of 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido [3,2-b: 2\',3\'-e][1,4] diazepin-6-one (nevirapine)'
[patent_app_type] => utility
[patent_app_number] => 10/862892
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2647
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059653.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862892 | Novel crystalline forms of 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido [3,2-b: 2',3'-e][1,4] diazepin-6-one (nevirapine) | Jun 6, 2004 | Abandoned |
Array
(
[id] => 7329950
[patent_doc_number] => 20040254163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them'
[patent_app_type] => new
[patent_app_number] => 10/862245
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51491
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254163.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862245
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862245 | Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them | Jun 6, 2004 | Issued |
Array
(
[id] => 7034315
[patent_doc_number] => 20050032825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Phosphorus-containing compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/862149
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31577
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862149 | Phosphorus-containing compounds and uses thereof | Jun 3, 2004 | Issued |
Array
(
[id] => 5101832
[patent_doc_number] => 20070185094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Novel 3-substitued-1,4-benzodiazepines'
[patent_app_type] => utility
[patent_app_number] => 10/558786
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17255
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558786 | Novel 3-substitued-1,4-benzodiazepines | May 26, 2004 | Abandoned |
Array
(
[id] => 655271
[patent_doc_number] => 07109326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Halo-alkoxycarbonyl prodrugs'
[patent_app_type] => utility
[patent_app_number] => 10/854388
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13339
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10854388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/854388 | Halo-alkoxycarbonyl prodrugs | May 24, 2004 | Issued |
Array
(
[id] => 7378226
[patent_doc_number] => 20040220174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Lactam-containing compounds and derivatives thereof as factor Xa inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/850587
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80063
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220174.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850587 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | May 19, 2004 | Issued |
Array
(
[id] => 418825
[patent_doc_number] => 07276497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Cytotoxic agents comprising new maytansinoids'
[patent_app_type] => utility
[patent_app_number] => 10/849136
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27324
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849136 | Cytotoxic agents comprising new maytansinoids | May 19, 2004 | Issued |
Array
(
[id] => 5057827
[patent_doc_number] => 20070060749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Process for preparing caprolactam by admixture of cyclohexanone oxime to a reaction mixture under turbulent flow conditions'
[patent_app_type] => utility
[patent_app_number] => 10/557770
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6271
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060749.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557770 | Process for preparing caprolactam by admixture of cyclohexanone oxime to a reaction mixture under turbulent flow conditions | May 16, 2004 | Issued |
Array
(
[id] => 885014
[patent_doc_number] => 07351820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-01
[patent_title] => 'Process for preparing caprolactam by Beckmann rearrangement'
[patent_app_type] => utility
[patent_app_number] => 10/557771
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6061
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/351/07351820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557771 | Process for preparing caprolactam by Beckmann rearrangement | May 16, 2004 | Issued |
Array
(
[id] => 900571
[patent_doc_number] => 07339056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-04
[patent_title] => 'Continuous process for preparing caprolactam'
[patent_app_type] => utility
[patent_app_number] => 10/557753
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6167
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/339/07339056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557753
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557753 | Continuous process for preparing caprolactam | May 16, 2004 | Issued |
Array
(
[id] => 765257
[patent_doc_number] => 07008613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-07
[patent_title] => 'Quaternary ammonium compounds'
[patent_app_type] => utility
[patent_app_number] => 10/843906
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4311
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/008/07008613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843906 | Quaternary ammonium compounds | May 11, 2004 | Issued |
Array
(
[id] => 5194408
[patent_doc_number] => 20070082892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 10/556576
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17658
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556576 | Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands | May 11, 2004 | Abandoned |
Array
(
[id] => 5101831
[patent_doc_number] => 20070185093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 10/556585
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17948
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556585 | Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands | May 11, 2004 | Abandoned |
Array
(
[id] => 649751
[patent_doc_number] => RE039308
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-09-26
[patent_title] => '3,5-dioxa-12-azawurtzitane compound and process of preparing same'
[patent_app_type] => reissue
[patent_app_number] => 10/840740
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1950
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840740 | 3,5-dioxa-12-azawurtzitane compound and process of preparing same | May 6, 2004 | Issued |
Array
(
[id] => 7427176
[patent_doc_number] => 20040229861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'CGRP receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/838835
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37180
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838835 | CGRP receptor antagonists | May 3, 2004 | Issued |
Array
(
[id] => 7276368
[patent_doc_number] => 20040235819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Benzoxazepinone derivatives'
[patent_app_type] => new
[patent_app_number] => 10/838054
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17145
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838054 | Benzoxazepinone derivatives | May 2, 2004 | Issued |
Array
(
[id] => 7190411
[patent_doc_number] => 20040204395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Water-soluble drugs and methods for their production'
[patent_app_type] => new
[patent_app_number] => 10/837785
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9814
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10837785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/837785 | Water-soluble drugs and methods for their production | May 2, 2004 | Issued |
Array
(
[id] => 803327
[patent_doc_number] => 07423031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Compounds and compositions as protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/836030
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24394
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10836030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/836030 | Compounds and compositions as protein kinase inhibitors | Apr 29, 2004 | Issued |
Array
(
[id] => 7276369
[patent_doc_number] => 20040235820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Preparation of hymenialdisine derivatives and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/833871
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14107
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833871 | Preparation of hymenialdisine derivatives and use thereof | Apr 27, 2004 | Issued |